PharmaResearch Co Ltd
KOSDAQ:214450
PharmaResearch Co Ltd
Operating Income
PharmaResearch Co Ltd
Operating Income Peer Comparison
Competitive Operating Income Analysis
Latest Figures & CAGR of Competitors
Company | Operating Income | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
P
|
PharmaResearch Co Ltd
KOSDAQ:214450
|
Operating Income
₩95.1B
|
CAGR 3-Years
34%
|
CAGR 5-Years
64%
|
CAGR 10-Years
N/A
|
Celltrion Inc
KRX:068270
|
Operating Income
₩479.3B
|
CAGR 3-Years
-16%
|
CAGR 5-Years
10%
|
CAGR 10-Years
18%
|
|
SK Bioscience Co Ltd
KRX:302440
|
Operating Income
-₩12B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Green Cross Corp
KRX:006280
|
Operating Income
₩33B
|
CAGR 3-Years
-12%
|
CAGR 5-Years
2%
|
CAGR 10-Years
-9%
|
|
H
|
Hugel Inc
KOSDAQ:145020
|
Operating Income
₩111.7B
|
CAGR 3-Years
6%
|
CAGR 5-Years
8%
|
CAGR 10-Years
N/A
|
A
|
Alteogen Inc
KOSDAQ:196170
|
Operating Income
-₩9.7B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
-5%
|
CAGR 10-Years
N/A
|
See Also
What is PharmaResearch Co Ltd's Operating Income?
Operating Income
95.1B
KRW
Based on the financial report for Mar 31, 2024, PharmaResearch Co Ltd's Operating Income amounts to 95.1B KRW.
What is PharmaResearch Co Ltd's Operating Income growth rate?
Operating Income CAGR 5Y
64%
Over the last year, the Operating Income growth was 43%. The average annual Operating Income growth rates for PharmaResearch Co Ltd have been 34% over the past three years , 64% over the past five years .